» Articles » PMID: 29891014

Hsa_circ_0046264 Up-regulated BRCA2 to Suppress Lung Cancer Through Targeting Hsa-miR-1245

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2018 Jun 13
PMID 29891014
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpful in lung cancer early diagnosis and clinical treatment.

Methods: Gene microarray data screened the differential gene of hsa_circ_0046264 and its downstream genes were found by bioinformatics analysis and verified by luciferase reporter assay. QRT-PCR and Western blot was used to detect the RNA and protein levels respectively. RNase R digestion confirmed the existences of circular RNA. Cell viability, invasion and apoptosis were determined by MTT assay, flow cytometry and DNA damage assay. Tumor formation in nude mice and immunohistochemistry proved the functions of hsa_circ_0046264 in vivo.

Results: Hsa_circ_0046264 and BRCA2 were down-regulated in lung cancer tissues while miR-1245 was up-regulated. Hsa_circ_0046264 induced apoptosis but inhibited proliferation and invasion of lung cancer cells through targeting miR-1245 to up-regulate BRCA2. Hsa_circ_0046264 inhibited the tumor growth in vivo.

Conclusion: Hsa_circ_0046264 was a tumor suppressor in lung cancer. Overexpression of hsa_circ_0046264 could up-regulate BRCA2 expression through down-regulating of miR-1245.

Citing Articles

Circular RNAs in lung cancer: implications for preventing therapeutic resistance.

Liu W, Sun Y, Huo Y, Zhang L, Zhang N, Yang M EBioMedicine. 2024; 107:105309.

PMID: 39191172 PMC: 11445705. DOI: 10.1016/j.ebiom.2024.105309.


The multifaceted roles of circular RNAs in cancer hallmarks: From mechanisms to clinical implications.

Kundu I, Varshney S, Karnati S, Naidu S Mol Ther Nucleic Acids. 2024; 35(3):102286.

PMID: 39188305 PMC: 11345389. DOI: 10.1016/j.omtn.2024.102286.


The role of circular RNAs (circRNAs) as a prognostic factor in lung cancer: a meta-analysis.

Ahsan S, Win T, Aye S, Than N BMC Cancer. 2024; 24(1):988.

PMID: 39123167 PMC: 11316314. DOI: 10.1186/s12885-024-12704-w.


Osteosarcoma in a ceRNET perspective.

Mosca N, Alessio N, Di Paola A, Marrapodi M, Galderisi U, Russo A J Biomed Sci. 2024; 31(1):59.

PMID: 38835012 PMC: 11151680. DOI: 10.1186/s12929-024-01049-y.


The Tumorigenic Role of Circular RNA-MicroRNA Axis in Cancer.

Kim W, Park E, Lee D, Lee Y, Bae W, Kim H Int J Mol Sci. 2023; 24(3).

PMID: 36769372 PMC: 9917898. DOI: 10.3390/ijms24033050.


References
1.
Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

2.
Zhong Z, Huang M, Lv M, He Y, Duan C, Zhang L . Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett. 2017; 403:305-317. DOI: 10.1016/j.canlet.2017.06.027. View

3.
Wan L, Zhang L, Fan K, Cheng Z, Sun Q, Wang J . Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway. Biomed Res Int. 2016; 2016:1579490. PMC: 5013215. DOI: 10.1155/2016/1579490. View

4.
Espinoza J, Takami A, Yoshioka K, Nakata K, Sato T, Kasahara Y . Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions. Haematologica. 2012; 97(9):1295-303. PMC: 3436229. DOI: 10.3324/haematol.2011.058529. View

5.
Zhang J, Sun J, Chen J, Yao L, Ouyang T, Li J . Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer. Breast Cancer Res Treat. 2016; 158(3):455-62. DOI: 10.1007/s10549-016-3902-0. View